Lv4
530 积分 2026-04-24 加入
Efficacy and safety of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis
3个月前
已完结
Etanercept for treatment of refractory Kawasaki disease: a randomised, double-blind, placebo-controlled trial
3个月前
已关闭
Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease
3个月前
已完结
Kawakinra: A phase IIA multicenter trial to assess the efficacy, and safety of anakinra in patients with intravenous immunoglobulinresistant Kawasaki disease
3个月前
已完结
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease
3个月前
已完结
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
3个月前
已完结
Safety and Feasibility of InfliximabTherapy in Children with Kawasaki Disease Who Received Live Vaccinations
4个月前
已关闭
Third-line therapies in patients with Kawasaki disease refractory to first- and second-line intravenous immunoglobulin therapy
4个月前
已完结
Etanercept with IVIg for acute Kawasaki disease: a long-term follow-up on the EATAK trial
4个月前
已完结
皖公网安备34019202002308
